Chris Bostick, Vice President
Chris Bostick, OCV Partners
  • Black LinkedIn Icon

Chris Bostick is a Vice President at OCV and is passionate about technologies enabling precision medicine. Prior to OCV Dr. Bostick obtained his Ph.D. in Pharmaceutical and Pharmacological Sciences from West Virginia University researching protein immobilization for studying electron transfer and protein-protein interactions in Cytochrome P450s. For his postdoctoral work, he studied precision medicine-based approaches for genetic epilepsies at the Institute for Genomic Medicine at Columbia University. Dr. Bostick holds a B.S. in Biology from Cornell University and a Ph.D. in Pharmacological and Pharmaceutical Sciences from West Virginia University.

 

Chris serves as a Board Member for the following portfolio companies:

  • Ossio

  • TORL